Screening for the synthetic cannabinoid JWH‐018 and its major metabolites in human doping controls

Drug Testing and Analysis - Tập 3 Số 9 - Trang 609-620 - 2011
Ines Möller1, Annette Wintermeyer, Katja Mercer‐Chalmers‐Bender, Martin Jübner, Andreas Thomas, Oliver Krug, Wilhelm Schänzer, Mario Thevis
1Institute of Biochemistry-Center for Preventive Doping Research, German Sport University Cologne, Germany.

Tóm tắt

Referred to as ‘spice’, several new drugs, advertised as herbal blends, have appeared on the market in the last few years, in which the synthetic cannabinoids JWH‐018 and a C8 homologue of CP 47,497 were identified as major active ingredients. Due to their reported cannabis‐like effects, many European countries have banned these substances. The World Anti‐Doping Agency has also explicitly prohibited synthetic cannabinoids in elite sport in‐competition. Since urine specimens have been the preferred doping control samples, the elucidation of the metabolic pathways of these substances is of particular importance to implement them in sports drug testing programmes. In a recent report, an in vitro phase‐I metabolism study of JWH‐018 was presented yielding mainly hydroxylated and N‐dealkylated metabolites. Due to these findings, a urine sample of a healthy man declaring to have smoked a ‘spice’ product was screened for potential phase‐I and ‐II metabolites by high‐resolution/high‐accuracy mass spectrometry in the present report. The majority of the phase‐I metabolites observed in earlier in vitro studies of JWH‐018 were detected in this urine specimen and furthermore most of their respective monoglucuronides. As no intact JWH‐018 was detectable, the monohydroxylated metabolite being the most abundant one was chosen as a target analyte for sports drug testing purposes; a detection method was subsequently developed and validated in accordance to conventional screening protocols based on enzymatic hydrolysis, liquid‐liquid extraction, and liquid chromatography/electrospray tandem mass spectrometry analysis. The method was applied to approximately 7500 urine doping control samples yielding two JWH‐018 findings and demonstrated its capability for a sensitive and selective identification of JWH‐018 and its metabolites in human urine. Copyright © 2010 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

Mustata C., 2009, Adicciones, 21, 181, 10.20882/adicciones.227

EMCDDA (European Monitoring Centre for Drugs and Drug Addiction). Available at:http://www.emcdda.europa.eu/publications/thematic‐papers/spice[January 2010].

10.1002/jms.1558

10.1248/cpb.57.439

C.SteupAvailable at:http://www.eve‐rave.ch/Images/analyse‐thc‐pharm‐spice‐jwh‐018.pdf[January 2010].

Compton D. R., 1992, J. Pharmacol. Exp. Ther., 260, 201

10.1111/j.1747-0285.2009.00910.x

10.1016/j.bmc.2004.09.050

WADA (World Anti‐Doping Agency). Available at:http://www.wada‐ama.org/rtecontent/document/2010_Prohibited_List_FINAL_EN_Web.pdf[January 2010].

10.2165/00007256-200333060-00001

Wiley J. L., 1998, J. Pharmacol. Exp. Ther., 285, 995

10.1016/S0968-0896(02)00451-0

10.1016/j.bmcl.2005.06.008

10.1021/jm00089a018

Krämer T., 2008, Toxichem Krimtech, 76, 90

A.Wintermeyer I.Möller M.Thevis M.Jübner J.Beike M. A.Rothschild K.Bender unpublished.

10.1007/s00216-006-0717-6

10.1016/j.forsciint.2010.04.003

10.1002/jms.873

10.1007/BF02269193

ICH (International Conference on Harmonization). Available at:http://www.ich.org/LOB/media/MEDIA417.pdf[January 2010].

Kromidas S., 2005, Validierung in der Analytik,

10.1016/S1044-0305(03)00574-9

10.1021/ac020361s

Auwärter V., 2008, Toxichem Krimtech, 775, 127

Mandel J., 1964, The Statistical Analysis of Experimental Data

10.1016/j.steroids.2008.10.004

Mareck U., 2004, Recent Advances in Doping Analysis, 65

WADA (World Anti‐Doping Agency). Available at:http://www.wada‐ama.org/rtecontent/document/criteria_1_2.pdf[January 2010].

Thông tin
Thông tin xuất bản

Drug Testing and Analysis

Tập 3 Số 9

609-620

Thông tin tác giả